UNIVERSITY OF MIAMI

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1925-01-01

Employees: 10K

Market Cap: -

Website: https://continue.miami.edu/packagedetail.aspx

Clinical Trials

Evaluating an Exercise Program to Reduce Cardiovascular Risk Factors in Children Infected With HIV

Not Applicable

Completed

Conditions: Cardiovascular Diseases
HIV
Acquired Immunodeficiency Syndrome

Interventions: Behavioral: Control Group
Behavioral: Exercise Program

First Posted Date: 2009-05-25

Last Posted Date: 2015-12-07

Lead Sponsor: University of Miami

Target Recruit Count: 16

Registration Number: NCT00908284

Locations: 🇺🇸
University of Miami, Department of Pediatrics, Division of Clinical Research, Batchelor Children's Research Institute, Miami, Florida, United States

Rituximab, Gemcitabine, and Vinorelbine in Treating Patients With Hodgkin Lymphoma That Has Relapsed or Not Responded to Treatment

Phase 2

Withdrawn

Conditions: Lymphoma

Interventions: Biological: rituximab
Drug: gemcitabine hydrochloride
Drug: vinorelbine ditartrate

First Posted Date: 2009-04-15

Last Posted Date: 2016-12-15

Lead Sponsor: University of Miami

Registration Number: NCT00881387

Locations: 🇺🇸
University of Miami Sylvester Comprehensive Cancer Center - Miami, Miami, Florida, United States

Rituximab and Combination Chemotherapy in Treating Patients With Previously Untreated Mantle Cell Lymphoma

Phase 2

Active, not recruiting

Conditions: Mantle-Cell Lymphoma

Interventions: Biological: G-CSF
Drug: Rituximab
Drug: Cyclophosphamide
Drug: Cytarabine
Drug: Doxorubicin
Drug: Etoposide
Drug: Ifosfamide
Drug: Leucovorin
Drug: Mesna
Drug: Methotrexate
Drug: Vincristine

First Posted Date: 2009-04-08

Last Posted Date: 2024-07-03

Lead Sponsor: University of Miami

Target Recruit Count: 25

Registration Number: NCT00878254

Locations: 🇺🇸
University of Miami, Miami, Florida, United States

Cisplatin or Carboplatin and Sorafenib in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery

Phase 2

Completed

Conditions: Liver Cancer

Interventions: Drug: Carboplatin
Drug: Cisplatin
Drug: Sorafenib

First Posted Date: 2009-04-03

Last Posted Date: 2017-02-07

Lead Sponsor: University of Miami

Target Recruit Count: 11

Registration Number: NCT00875615

Locations: 🇺🇸
University of Miami Sylvester Comprehensive Cancer Center - Miami, Miami, Florida, United States

Parent Educational Program for Children With Sickle Cell Disease

Not Applicable

Completed

Conditions: Hemoglobin SC Disease
Anemia, Sickle Cell

Interventions: Behavioral: Parent Educational Support

First Posted Date: 2009-03-12

Last Posted Date: 2021-08-02

Lead Sponsor: University of Miami

Target Recruit Count: 73

Registration Number: NCT00860782

Locations: 🇺🇸
Mailman Center for Child Development, Miami, Florida, United States

Racial Differences in Phosphorus Metabolism

Not Applicable

Completed

Conditions: Control

Interventions: Drug: 1-34 parathyroid infusion

First Posted Date: 2009-03-06

Last Posted Date: 2017-09-11

Lead Sponsor: University of Miami

Target Recruit Count: 26

Registration Number: NCT00856726

Locations: 🇺🇸
University of Miami, Miami, Florida, United States

Zidovudine, Interferon Alfa-2b, PEG-Interferon Alfa-2b in Patients With HTLV-I Associated Adult T-Cell Leukemia/Lymphoma

Phase 4

Terminated

Conditions: Lymphoma
Precancerous/Nonmalignant Condition

Interventions: Biological: PEG-interferon alfa-2b
Biological: Interferon alfa-2b
Drug: Zidovudine
Drug: Valproic Acid

First Posted Date: 2009-03-03

Last Posted Date: 2018-04-17

Lead Sponsor: University of Miami

Target Recruit Count: 13

Registration Number: NCT00854581

Locations: 🇺🇸
University of Miami Sylvester Comprehensive Cancer Center - Miami, Miami, Florida, United States

Kuvan Therapy in Phenylketonuria (PKU): The Effect of Blood Phenylalanine Concentration on Kuvan Response

Phase 2

Completed

Conditions: Phenylketonuria

Interventions: Drug: Kuvan
Other: Diet

First Posted Date: 2009-02-11

Last Posted Date: 2019-12-03

Lead Sponsor: University of Miami

Target Recruit Count: 21

Registration Number: NCT00841100

Locations: 🇺🇸
Department of Biochemistry & Molecular Biology, Miami, Florida, United States

Pilot Study of Ranibizumab (Lucentis) for Uveitic Cystoid Macular Edema

Phase 1

Completed

Conditions: Uveitic Cystoid Macular Edema

Interventions: Drug: ranibizumab

First Posted Date: 2009-01-22

Last Posted Date: 2014-08-26

Lead Sponsor: University of Miami

Target Recruit Count: 6

Registration Number: NCT00826618

Locations: 🇺🇸
Bascom Palmer Eye Insitute, Miami, Florida, United States
🇺🇸
Bascom Palmer of the Palm Beaches, Palm Beach Gardens, Florida, United States

Rapid HIV Testing and Counseling in Drug Abuse Treatment

Phase 3

Completed

Conditions: Substance-Related Disorders

Interventions: Behavioral: On- site HIV rapid test & information
Behavioral: Referral for off-site HIV testing
Behavioral: On-site HIV rapid test and brief, prevention counseling

First Posted Date: 2008-12-17

Last Posted Date: 2015-10-14

Lead Sponsor: University of Miami

Target Recruit Count: 1281

Registration Number: NCT00809445

Locations: 🇺🇸
Chesterfield CSB Substance Abuse Service, Chesterfield, Virginia, United States
🇺🇸
Daymark Recovery Services, Inc., Salisbury, North Carolina, United States
🇺🇸
Wheeler Clinic, Plainville, Connecticut, United States

and more 9 locations

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy